Palvella Therapeutics宣布，任命在美国颇具声望的儿科皮肤科专家James R. Treat博士出任首席医疗官一职。这一重要人事任命标志着公司在临床开发和医学战略推进上迈出关键一步。Treat博士的加入，将为公司带来深厚的皮肤科专业知识和丰富的临床研究经验。作为全国公认的儿科皮肤科权威，他在罕见皮肤病诊疗领域拥有卓越建树，有望为Palvella的在研管线注入新的学术动力与临床洞察。公司方面对Treat博士的加盟表示高度期待，认为其在儿科皮肤科领域的专业造诣和领导能力，将有力助推公司推进创新疗法的开发与注册进程。Palvella Therapeutics是一家专注于罕见皮肤病创新疗法开发的临床阶段生物制药公司，此次引入重量级医学人才，再次彰显了公司构建高水平临床团队、加速核心产品管线的坚定决心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.